Cardiac biomarkers in chronic renal disease

References

• Schiffrin E. L., Lipman M. L., Mann J. F. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 85–97
   PubMedGoogle Scholar
• Wison S., Foo K., Cunningham J., Cooper J., Deaner A., Knight C., et al. Renal function and risk stratification in acute coronary syndromes. Am J Cardiol 2003; 1051–4
   PubMedGoogle Scholar
• Wu A. H., Laios I., Green S., Gornet T. G., Wong S. S., Parmley L., et al. Immunoassays for serum and urine myoglobin: myoglobin clearance assessed as a risk factor for acute renal failure. Clin Chem 1994; 796–802
   PubMedGoogle Scholar
• Katus H. A., Looser S., Hallermayer K., Remppis A., Scheffold T., Borgya A., et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 1992; 386–93
   PubMedGoogle Scholar
• Collinson P. O., Chandler H. A., Stubbs P. J., Moseley D. S., Lewis D., Simmons M. D. Measurement of serum troponin T, creatine kinase MB isoenzyme, and total creatine kinase following arduous physical training. Ann Clin Biochem 1995; 450–3
   PubMedGoogle Scholar
• Adams J. E III., Bodor G. S., Davila‐Roman V. G., Delmez J. A., Apple F. S., Ladenson J. H., et al. Cardiac troponin I. A marker with high specificity for cardiac injury [see comments]. Circulation 1993; 101–6
   PubMedGoogle Scholar
• Bhayana V., Gougoulias T., Cohoe S., Henderson A. R. Discordance between results for serum troponin T and troponin I in renal disease [see comments]. Clin Chem 1995; 312–17
   PubMedGoogle Scholar
• Collinson P. O., Stubbs P. J., Rosalki S. B. Cardiac troponin T in renal disease. Clin Chem 1995; 1671–3
   PubMedGoogle Scholar
• Muller‐Bardorff M., Hallermayer K., Schroder A., Ebert C., Borgya A., Gerhardt W., et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation [see comments]. Clin Chem 1997; 458–66
   PubMedGoogle Scholar
• Collinson P. O., Hadcocks L., Foo Y., Rosalki S. B., Stubbs P. J., Morgan S. H., et al. Cardiac troponins in patients with renal dysfunction. Ann Clin Biochem 1998; 380–6
   PubMedGoogle Scholar
• Hickman P. E., Koerbin G., Southcott E., Tate J., Dimeski G., Carter A., et al. Newer cardiac troponin I assays have similar performance to troponin T in patients with end‐stage renal disease. Ann Clin Biochem 2007; 285–9
   PubMedGoogle Scholar
• Bodor G. S., Survant L., Voss E. M., Smith S., Porterfield D., Apple F. S. Cardiac troponin T composition in normal and regenerating human skeletal muscle [see comments]. Clin Chem 1997; 476–84
   PubMedGoogle Scholar
• Haller C., Zehelein J., Remppis A., Muller‐Bardorff M., Katus H. A. Cardiac troponin T in patients with end‐stage renal disease: absence of expression in truncal skeletal muscle [published erratum appears in Clin Chem 1998 Jul;44(7):1586] [see comments]. Clin Chem 1998; 930–8
   PubMedGoogle Scholar
• Fredericks S., Bainbridge K., Murray J. F., Collinson P. O., Carter N. D., Holt D. W. Measurement of cardiac troponin I in striated muscle using three experimental methods. Ann Clin Biochem 2003; 244–8
   PubMedGoogle Scholar
• Fredericks S., Degens H., McKoy G., Bainbridge K., Collinson P. O., Coulton G., et al. Effect of denervation on the content of cardiac troponin‐T and cardiac troponin‐I in rat skeletal muscle. Clin Biochem 2007; 423–6
   PubMedGoogle Scholar
• Khan N. A., Hemmelgarn B. R., Tonelli M., Thompson C. R., Levin A. Prognostic value of troponin T and I among asymptomatic patients with end‐stage renal disease: a meta‐analysis. Circulation 2005; 3088–96
   PubMedGoogle Scholar
• Aviles R. J., Askari A. T., Lindahl B., Wallentin L., Jia G., Ohman E. M., et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002; 2047–52
   PubMedGoogle Scholar
• Thygesen K., Alpert J. S., White H. D. Universal definition of myocardial infarction. J Am Coll Cardiol 2007; 2173–95
   PubMedGoogle Scholar
• Diris J. H., Hackeng C. M., Kooman J. P., Pinto Y. M., Hermens W. T., Dieijen‐Visser M. P. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 2004; 23–5
   PubMedGoogle Scholar
• Fahie‐Wilson M. N., Carmichael D. J., Delaney M. P., Stevens P. E., Hall E. M., Lamb E. J. Cardiac troponin T circulates in the free, intact form in patients with kidney failure. Clin Chem 2006; 414–20
   PubMedGoogle Scholar
• Sharma R., Gaze D. C., Pellerin D., Mehta R. L., Gregson H., Streather C. P., et al. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart 2006; 804–9
   PubMedGoogle Scholar
• Sharma R., Pellerin D., Gaze D. C., Shah J. S., Streather C. P., Collinson P. O., et al. Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates. Eur J Echocardiogr 2005; 327–35
   PubMedGoogle Scholar
• deFilippi C. R., Thorn E. M., Aggarwal M., Joy A., Christenson R. H., Duh S. H., et al. Frequency and cause of cardiac troponin T elevation in chronic hemodialysis patients from study of cardiovascular magnetic resonance. Am J Cardiol 2007; 885–9
   PubMedGoogle Scholar
• Goetze J. P., Jensen G., Moller S., Bendtsen F., Rehfeld J. F., Henriksen J. H. BNP and N‐terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest 2006; 8–15
   PubMedGoogle Scholar
• DeFilippi C., van Kimmenade R. R., Pinto Y. M. Amino‐terminal pro‐B‐type natriuretic peptide testing in renal disease. Am J Cardiol 2008; 82–8
   PubMedGoogle Scholar
• Zoccali C., Mallamaci F., Benedetto F. A., Tripepi G., Parlongo S., Cataliotti A., et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 1508–15
   PubMedGoogle Scholar
• Sharma R., Gaze D. C., Pellerin D., Mehta R. L., Gregson H., Streather C. P., et al. Raised plasma N‐terminal pro‐B‐type natriuretic peptide concentrations predict mortality and cardiac disease in end‐stage renal disease. Heart 2006; 1518–19
   PubMedGoogle Scholar
• Hawkridge A. M., Heublein D. M., Bergen HR I. I. I., Cataliotti A., Burnett JC J. r., Muddiman D. C. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP‐32) in severe human heart failure. Proc Natl Acad Sci USA 2005; 17442–7
   PubMedGoogle Scholar
• Giuliani I., Rieunier F., Larue C., Delagneau J. F., Granier C., Pau B., et al. Assay for measurement of intact B‐type natriuretic peptide prohormone in blood. Clin Chem 2006; 1054–61
   PubMedGoogle Scholar
• Seferian K. R., Tamm N. N., Semenov A. G., Mukharyamova K. S., Tolstaya A. A., Koshkina E. V., et al. The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure. Clin Chem 2007; 866–73
   PubMedGoogle Scholar